SCHEMBL2905623

SCHEMBL2905623

Nc1nc(NCCCn2cc(-c3ccc(Cl)cc3Cl)cc2C(=O)NCc2ccncc2)ccc1[N+](=O)[O-]

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 4/20 0.47
GSK3A P49840 3/20 0.47
CDK1 P06493 2/20 0.47
CCNB2 O95067 1/20 0.44
CCNB1 P14635 1/20 0.44
CCNB3 Q8WWL7 1/20 0.44
POLB P06746 2/20 0.40
HTT P42858 5/20 0.37
ALDH1A1 P00352 3/20 0.37
MAPT P10636 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
HPGD P15428 4/20 0.36
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2C19 P33261 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
DPP4 P27487 1/20 0.35
DPP8 Q6V1X1 1/20 0.35
DPP9 Q86TI2 1/20 0.35
MARS1 P56192 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2904701 0.94 GSK3B (0.46) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2937412 0.93 GSK3B (0.46) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2910255 0.92 POLB (0.52) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2910272 0.90 GSK3B (0.45) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2913436 0.89 GSK3B (0.48) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2911865 0.88 GSK3B (0.45) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2913513 0.87 GSK3B (0.45) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2904013 0.87 GSK3B (0.52) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2903944 0.87 GSK3B (0.51) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2911878 0.87 GSK3B (0.48) GSK3BGSK3ACDK1CCNB2CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed